Kawasumi Laboratories Inc. | Mutual Funds
Mutual Funds that own Kawasumi Laboratories Inc.
DFA International Small Cap Value Portfolio
357,920
1.56%
17,100
0.01%
04/30/2018
Fidelity Series Intrinsic Opportunities Fund
100,000
0.44%
0
0.01%
04/30/2018
DFA Japanese Small Company Series
93,880
0.41%
13,800
0.02%
01/31/2018
Nomura Asset Amundi Japan Target Japan Mother Fund
57,600
0.25%
-96,299
0.11%
02/20/2017
DFA International Core Equity Portfolio
54,500
0.24%
3,700
0%
04/30/2018
19,000
0.08%
19,000
1.91%
06/30/2017
DIAM (Japan) Growth Equity Open Mother Fund
16,500
0.07%
200
0.17%
06/21/2017
DFA International Vector Equity Portfolio
13,100
0.06%
0
0%
04/30/2018
VermogensParapluFonds - Acadian Pacific Equity
12,700
0.06%
0
0.13%
06/30/2017
SEI Global Master Fund Plc - Japan Equity Fund
9,800
0.04%
0
0.02%
06/30/2018
| Address |
Shinagawa Intercity Tower B, 9/F
Tokyo Tokyo 108
Japan
|
|
Employees
|
- |
| Website |
http://www.kawasumi.jp |
| Updated |
07/08/2019 |
| Kawasumi Laboratories, Inc. engages in the manufacture and sale of medical devices and pharmaceuticals. It operates through the following segments: Blood Transfusion and Endovascular; and Hemodialysis and Plasmapheresis. The Blood Transfusion and Endovascular segment produces blood bags, blood collection kit, administration kit, catheter and stent-graft. |
